Bardin Hill Management Partners’s Acceleron Pharma XLRN Stock Holding History

Bardin Hill Management Partners’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-26,448	Closed	-$4.55M	–	108
2021 Q3	$4.55M	Buy	+26,448	New	+$3.46M	0.74%	33

Bardin Hill Management Partners's XLRN Position: Q4 2021 in Review

Bardin Hill Management Partners sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 26,448 shares — an estimated $4.55M sold.

Bardin Hill Management Partners first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $4.55M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Bardin Hill Management Partners reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Bardin Hill Management Partners sold 26,448 Acceleron Pharma shares in Q4 2021, an estimated $4.55M.
Bardin Hill Management Partners first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Bardin Hill Management Partners's Acceleron Pharma position peaked at $4.55M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Bardin Hill Management Partners's 13F filing for Q4 2021, filed 14 Feb 2022.